Zobrazeno 1 - 10
of 127
pro vyhledávání: '"K A, Dicke"'
Publikováno v:
The International Journal of Cell Cloning. 10:88-91
Autor:
M Arneson, J W Gurney, Elizabeth C. Reed, James Linder, S. I. Rennard, W P Vaughan, R J Witte, K A Dicke, R A Robbins
Publikováno v:
American Journal of Roentgenology. 157:461-464
Diffuse alveolar hemorrhage is a life-threatening complication after bone marrow transplantation. We investigated the radiographic abnormalities that occurred in 39 transplantation patients with a diagnosis of diffuse alveolar hemorrhage and correlat
Autor:
J Spinolo, Terry L. Smith, Ronald S. Walters, B Barlogie, M. J. Keating, Hagop M. Kantarjian, Yang O. Huh, Susan O'Brien, Elihu H. Estey, K. A. Dicke
Publikováno v:
Journal of Clinical Oncology. 8:994-1004
One hundred five untreated adult patients with acute lymphocytic leukemia (ALL) were entered on the vincristine, Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH), and Decadron (dexamethasone; Merck Sharp and Dohme, West Point, PA) (VAD) reg
Publikováno v:
The International Journal of Cell Cloning. 10:50-52
Short term incubation of bone marrow cells for 1 hour at 37°C with hematopoietic growth factors: IL-3, GM-CSF, and G-CSF either alone or in combination augmented GM-CFC production as measured in the 7 day liquid culture system. The increase of proge
Publikováno v:
Cancer. 80
Indium-111 labeled antiferritin targets 95% of all Hodgkin's disease lesions with a diameter of 1 cm or more. Subsequent treatment with yttrium-90 labeled antiferritin secures a high response rate in patients with recurrent Hodgkin's disease.A total
Autor:
K A, Dicke, D L, Hood, M, Arneson, L, Fulbright, A, DiStefano, B, Firstenberg, J, Adams, G R, Blumenschein
Publikováno v:
Experimental hematology. 25(1)
The brief administration of G-CSF to previously treated solid tumor patients has a positive impact on the overall cellularity and progenitor cell content of harvested bone marrow. Fifty-seven patients, fully recovered from therapy and growth factor s
Autor:
R P, Gale, T, Büchner, M J, Zhang, A, Heinecke, R E, Champlin, K A, Dicke, E, Gluckman, R A, Good, A, Gratwohl, R H, Herzig, A, Keating, J P, Klein, A M, Marmont, H G, Prentice, P A, Rowlings, K A, Sobocinski, B, Speck, R S, Weiner, M M, Horowitz
Publikováno v:
Leukemia. 10(11)
There is controversy whether adults with acute myelogenous leukemia (AML) in first remission are best treated with chemotherapy or an HLA-identical sibling bone marrow transplant. We studied 1097 adults, 16-50 years old, with AML in first remission.
Publikováno v:
Experimental hematology. 24(10)
Radiolabeled immunoglobulin therapy (RIT) is a new cancer treatment that is more selective than its predecessors. Its dose-limiting normal tissue side effect is bone marrow toxicity, and hematopoietic stem cell damage appears to be its most significa
Autor:
R P, Gale, M M, Horowitz, J K, Rees, R G, Gray, M M, Oken, E H, Estey, K M, Kim, M J, Zhang, R C, Ash, K, Atkinson, R E, Champlin, K A, Dicke, J L, Gajewski, J M, Goldman, W, Helbig, P S, Henslee-Downey, W, Hinterberger, N, Jacobsen, A, Keating, J P, Klein, A M, Marmont, H G, Prentice, J, Reiffers, A A, Rimm, M M, Bortin
Publikováno v:
Leukemia. 10(1)
The best therapy for persons with acute myelogenous leukemia (AML) in 2nd remission is unknown. Bone marrow transplants from an HLA-identical sibling are reported to be better than chemotherapy but this is controversial. The objective of the study wa
Autor:
K A, Dicke, D L, Hood, S, Hanks, M, Vaughan, L, Fulbright, J A, Dicke, M, Arneson, G, Blumenschein
Publikováno v:
Experimental hematology. 23(11)
This report details a bone marrow harvest procedure performed outside the hospital setting under local anesthesia, thereby avoiding many of the risks associated with the traditional surgical procedure. In approximately 30 minutes, 450 milliliters of